Header cover image

Pharmaceuticals & Biotech Biotech Breakthroughs

Results

108

0 new

Companys with strong funding and high growth potential

108 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

PHIO

Phio Pharmaceuticals		US$3.570.6%-73.0%US$2.9mUS$36.00PB0.8xE183.3%n/a

IMUX

Immunic		US$1.50-23.1%4.9%US$135.1mUS$12.75PB2.1xE75.0%n/a

ARCT

Arcturus Therapeutics Holdings		US$21.773.6%-14.4%US$576.3mUS$77.26PS3.6xE68.2%n/a

CTKB

Cytek Biosciences		US$5.20-1.7%-14.2%US$665.4mUS$8.70PS3.5xE111.9%n/a

BLFS

BioLife Solutions		US$24.17-6.0%72.0%US$1.1bUS$28.67PS8xE72.5%n/a

VNDA

Vanda Pharmaceuticals		US$4.741.9%8.7%US$282.7mUS$8.07PS1.5xE79.7%n/a

EVO

Evotec		€3.49-4.1%-64.2%€1.1b€7.80PS1.4xE73.4%n/a

HITI

High Tide		CA$1.95-8.9%2.6%CA$217.0mCA$4.52PB1.5xE143.3%n/a

CDXC

ChromaDex		US$3.782.2%168.1%US$287.7mUS$6.54PS3.4xE102.9%n/a

ICPT

Intercept Pharmaceuticals		US$19.000.1%19.1%US$794.7mUS$19.00PS2.5xE42.4%n/a

BEIG.F

BeiGene		US$15.500%11.6%US$22.0bUS$19.99PS7.3xE64.1%n/a

PHAR

Pharming Group		€8.03-0.1%-37.4%€482.3m€20.14PS1.9xE64.6%n/a

TBPH

Theravance Biopharma		US$8.06-1.8%-3.8%US$389.4mUS$13.20PS6.4xE57.2%n/a

OGI

Organigram Holdings		CA$1.77-3.8%36.2%CA$254.1mCA$2.64PS1.7xE143.5%n/a

KNSA

Kiniksa Pharmaceuticals International		US$23.96-8.7%37.5%US$1.7bUS$35.00PS5xE53.2%n/a

ALMR.Y

Almirall		€9.900%n/a€1.9b€13.07PS2xE50.7%2.1%

EBS

Emergent BioSolutions		US$7.284.1%119.9%US$320.9mUS$8.00PB1xE106.4%n/a

HCM

HUTCHMED (China)		UK£18.429.6%8.7%UK£2.3bUK£30.37PS5.1xE48.2%n/a

PHGU.F

Pharming Group		€0.750%-41.9%€482.3m€1.89PS1.9xE64.8%n/a

INVV.Y

Indivior		UK£21.85-0.5%28.4%UK£2.4bUK£30.38PS3.2xE40.4%0%

GALD.Y

Galderma Group		CHF 19.131.5%n/aCHF 18.8bCHF 19.53PS5.2xE44.2%n/a

RGEN

Repligen		US$147.181.0%-8.1%US$7.8bUS$193.82PS13.7xE85.3%n/a

BGNE

BeiGene		US$212.537.0%15.4%US$22.0bUS$274.14PS7.3xE64.1%n/a

DBCC.F

Decibel Cannabis		CA$0.049-8.5%-60.8%CA$24.5mn/aPB0.6xE147.9%n/a
Page 4 of 5
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.